The Role of Immune Mechanisms, Inflammatory Pathways, and Macrophage Activation Syndrome in the Pathogenesis of Hemophagocytic Lymphohistiocytosis

被引:5
|
作者
Bseiso, Omair [1 ]
Zahdeh, Anas [1 ]
Isayed, Obay [2 ]
Mahagna, Seewar [2 ]
Bseiso, Anan [1 ,3 ]
机构
[1] Hebron Univ, Coll Med, Hebron, Palestine
[2] An Najah Natl Univ, Coll Med, Nablus, Palestine
[3] Al Quds Univ, Coll Med, Jerusalem, Palestine
关键词
pathophysiology; macrophage activation syndrome; hlh; hemophagocytic lymphohistiocytosis; hyperinflammatory response; CYTOKINE; DIAGNOSIS; DEFECTS; UPDATE; CELLS;
D O I
10.7759/cureus.33175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review article describes the pathophysiology of hemophagocytic lymphohistiocytosis (HLH). The condition is characterized by excessive stimulation of inflammatory cytokines, lymphocytes, and macrophages, leading to hyperinflammatory disorder with immune dysfunction. The main clinical and diagnostic features include fever >= 38.5 degrees C, splenomegaly, hyperferritinemia, cytopenia, hypofibrinogenemia, hemophagocytosis on the bone marrow, low or absent of natural killer (NK) cell activity, and elevated soluble CD25. Various immunological and inflammatory mechanisms are involved in the pathogenesis of HLH. Moreover, the condition can result in multisystem organ failure, contributing to the high mortality rate in hospital settings.A thorough literature search was conducted by collecting data from multiple articles published on PubMed, Medline, and Google Scholar. The article discusses the cellular and molecular pathways that lead to HLH. Due to the high rate of morbidity and mortality, early diagnosis needs to be established. More research pertaining to molecular biology, immunology, and the genetics of HLH is needed to explore the effective management and treatment of this rare disorder.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature
    Gioia, Chiara
    Paroli, Marino
    Izzo, Raffaella
    Di Sanzo, Lorenzo
    Rossi, Elisabetta
    Pignatelli, Pasquale
    Accapezzato, Daniele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [2] Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome
    Jesudas, Rohith
    Nichols, Kim E.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 22 (06) : 364 - 370
  • [3] Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome
    Valade, Sandrine
    Mariotte, Eric
    Azoulay, Elie
    CRITICAL CARE CLINICS, 2020, 36 (02) : 415 - +
  • [4] Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?
    Grom, AA
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (05) : 587 - 590
  • [5] Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis
    Horne, AnnaCarin
    Greenwood, Tatiana von Bahr
    Chiang, Samuel C. C.
    Meeths, Marie
    Bjorklund, Caroline
    Ekelund, Maria
    Erensjo, Peter
    Berg, Stefan
    Hagelberg, Stefan
    Bryceson, Yenan T.
    Andersson, Ulf
    Henter, Jan-Inge
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (10) : 1596 - 1602
  • [6] Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel
    Maria Martin-Rojas, Reyes
    Gomez-Centurion, Ignacio
    Bailen, Rebeca
    Bastos, Mariana
    Diaz-Crespo, Francisco
    Carbonell, Diego
    Correa-Rocha, Rafael
    Pion, Marjorie
    Munoz, Cristina
    Sancho, Milagros
    Gomez Fernandez, Isabel
    Oarbeascoa, Gillen
    Perez-Corral, Ana
    Martinez-Laperche, Carolina
    Anguita, Javier
    Buno, Ismael
    Menarguez, Javier
    Luis Diez-Martin, Jose
    Kwon, Mi
    CLINICAL CASE REPORTS, 2022, 10 (01):
  • [7] Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: A multidisciplinary challenge
    Ruffer, Nikolas
    Kosch, Ricardo
    Weisel, Katja
    Koetter, Ina
    Krusche, Martin
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (05): : 376 - 386
  • [8] Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis and Kawasaki Disease
    Simonini, Gabriele
    Pagnini, Ilaria
    Innocenti, Letizia
    Calabri, Giovanni Battista
    De Martino, Maurizio
    Cimaz, Rolando
    PEDIATRIC BLOOD & CANCER, 2010, 55 (03) : 591 - 591
  • [9] Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin
    Sztajnbok, Flavio
    Fonseca, Adriana Rodrigues
    Campos, Leonardo Rodrigues
    Lino, Katia
    Rodrigues, Marta Cristine Felix
    Silva, Rodrigo Moulin
    de Almeida, Rozana Gasparello
    Perazzio, Sandro Felix
    Carvalho, Margarida de Fatima Fernandes
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [10] A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults
    Bharat Kumar
    Sohaib Aleem
    Hana Saleh
    Jennifer Petts
    Zuhair K. Ballas
    Journal of Clinical Immunology, 2017, 37 : 638 - 643